Seeing Is Believing
Currently out of the existing stock ratings of Jotin Marango, 10 are a BUY (90.91%), 1 are a HOLD (9.09%).
Analyst Jotin Marango, carries an average stock price target met ratio of 33.33% that have a potential upside of 64.35% achieved within 118 days. Previously, Jotin Marango worked at ROTH.
Jotin Marango’s has documented 24 price targets and ratings displayed on 7 stocks. The coverage was on Healthcare, Technology sectors.
Most recent stock forecast was given on VSTM, Verastem at 14-May-2019.
Analyst best performing recommendations are on ARQL (ARQULE).
The best stock recommendation documented was for ARQL (ARQULE) at 2/22/2018. The price target of $5 was fulfilled within 92 days with a profit of $3.21 (179.33%) receiving and performance score of 19.49.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 19-Dec-2019
$18
5 years 7 months 7 days ago
(01-Sep-2020)
3/3 (100%)
$3.19 (21.54%)
78
Buy Since 03-Jun-2019
$60
5 years 7 months 8 days ago
(31-Aug-2020)
0/19 (0%)
$41.31 (221.03%)
Buy Since 14-Jun-2016
$34.5
$0.01 (0.03%)
$66
5 years 7 months 8 days ago
(31-Aug-2020)
1/9 (11.11%)
$0.28 (0.82%)
39
Hold Since 04-Feb-2020
$34.5
$0.01 (0.03%)
5 years 7 months 8 days ago
(31-Aug-2020)
5/5 (100%)
$0.28 (0.82%)
138
Buy Since 17-Nov-2015
$35
$0.51 (1.48%)
5 years 7 months 8 days ago
(31-Aug-2020)
5/14 (35.71%)
$0.78 (2.28%)
488
What Year was the first public recommendation made by Jotin Marango?